International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005

Area of Science:

• Public Health
• Epidemiology
• Infectious Diseases

Background:

• The International Circumpolar Surveillance System monitors invasive bacterial diseases in Arctic populations.
• Invasive pneumococcal disease (IPD) remains a significant health concern in Arctic regions, particularly among indigenous populations and young children.

Purpose of the Study:

• To analyze clinical findings, disease rates, serotype distribution, and antimicrobial susceptibility of IPD in Arctic countries.
• To evaluate the impact of the 7-valent pneumococcal conjugate vaccine (PCV7) on IPD incidence and serotype distribution.

Main Methods:

• Population-based surveillance data from the International Circumpolar Surveillance System were analyzed.
• 11,244 cases of invasive pneumococcal disease (IPD) were reported and analyzed for clinical characteristics, incidence rates, and serotype prevalence.
• Trends in IPD rates and serotype distribution were examined before and after the introduction of PCV7 in Alaska, northern Canada, and Norway.

Main Results:

• Pneumonia and bacteremia were the most common clinical presentations of IPD.
• IPD rates were notably high among indigenous populations in Alaska (43/100,000) and northern Canada (38/100,000).
• Following PCV7 introduction, IPD rates caused by vaccine serotypes decreased by over 80% in children under 2 years in Alaska and northern Canada, but IPD caused by non-PCV7 serotypes increased in Alaska.

Conclusions:

• Invasive pneumococcal disease (IPD) incidence is disproportionately high among indigenous peoples and young children in Arctic nations.
• Routine infant vaccination with the 7-valent pneumococcal conjugate vaccine (PCV7) has demonstrated effectiveness in reducing IPD caused by vaccine serotypes.
• The increase in non-PCV7 serotypes following PCV7 introduction highlights the need for ongoing surveillance and potentially broader-spectrum vaccines.